Ha Nguyen

Ha Nguyen

Auto-generated profile, based on publicly available information

Ha Nguyen

Department of Computer Science, Wayne State University , 5057 Woodward Avenue, Detroit, MI 48202

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2024 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
HNHung Nguyen
Hung Nguyen
HNHa Nguyen
Ha Nguyen
DTDuc Tran
Duc Tran
SDSorin Draghici
Sorin Draghici
TNTin Nguyen
Tin Nguyen
Single-cell RNA sequencing (scRNA-Seq) is a recent technology that allows for the measurement of the expression of all genes in each individual cell contained in a sample. Information at the single-cell level has been shown to be extremely useful in many areas. However, performing single-cell experiments is expensive. Although cellular deconvolution cannot provide the same comprehensive information as single-cell experiments, it can extract cell-type information from bulk RNA data, and therefore it allows researchers to conduct studies at cell-type resolution from existing bulk datasets. For these reasons, a great effort has been made to develop such methods for cellular deconvolution. The large number of methods available, the requirement of coding skills, inadequate documentation, and lack of performance assessment all make it extremely difficult for life scientists to choose a suitable method for their experiment. This paper aims to fill this gap by providing a comprehensive review of 53 deconvolution methods regarding their methodology, applications, performance, and outstanding challenges. More importantly, the article presents a benchmarking of all these 53 methods using 283 cell types from 30 tissues of 63 individuals. We also provide an R package named DeconBenchmark that allows readers to execute and benchmark the reviewed methods (https://github.com/tinnlab/DeconBenchmark).

4 March 2025 in Briefings in Bioinformatics
Verified
Journal Article
Open access
DTDao Tran
Dao Tran
HNHa Nguyen
Ha Nguyen
VPVan-Dung Pham
Van-Dung Pham
PNPhuong Nguyen
Phuong Nguyen
HLHUNG LUU
HUNG LUU
TNTin Nguyen
Tin Nguyen
Cancer is an umbrella term that includes a wide spectrum of disease severity, from those that are malignant, metastatic, and aggressive to benign lesions with very low potential for progression or death. The ability to prognosticate patient outcomes would facilitate management of various malignancies: patients whose cancer is likely to advance quickly would receive necessary treatment that is commensurate with the predicted biology of the disease. Former prognostic models based on clinical variables (age, gender, cancer stage, tumor grade, etc.), though helpful, cannot account for genetic differences, molecular etiology, tumor heterogeneity, and important host biological mechanisms. Therefore, recent prognostic models have shifted toward the integration of complementary information available in both molecular data and clinical variables to better predict patient outcomes: vital status (overall survival), metastasis (metastasis-free survival), and recurrence (progression-free survival). In this article, we review 20 survival prediction approaches that integrate multi-omics and clinical data to predict patient outcomes. We discuss their strategies for modeling survival time (continuous and discrete), the incorporation of molecular measurements and clinical variables into risk models (clinical and multi-omics data), how to cope with censored patient records, the effectiveness of data integration techniques, prediction methodologies, model validation, and assessment metrics. The goal is to inform life scientists of available resources, and to provide a complete review of important building blocks in survival prediction. At the same time, we thoroughly describe the pros and cons of each methodology, and discuss in depth the outstanding challenges that need to be addressed in future method development.

16 February 2023 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
JAJosh Abbott
Josh Abbott
MTMitali Tambe
Mitali Tambe
IPIvan Pavlinov
Ivan Pavlinov
AFAtena Farkhondeh
Atena Farkhondeh
HNHa Nam Nguyen
Ha Nam Nguyen
Wei ZhengWei Zheng
Wei Zheng
NGLY1 deficiency is an ultra-rare, autosomal recessive genetic disease caused by mutations in the NGLY1 gene encoding N-glycanase one that removes N-linked glycan. Patients with pathogenic mutations in NGLY1 have complex clinical symptoms including global developmental delay, motor disorder and liver dysfunction. To better understand the disease pathogenesis and the neurological symptoms of the NGLY1 deficiency we generated and characterized midbrain organoids using patient-derived iPSCs from two patients with distinct disease-causing mutations–one homozygous for p. Q208X, the other compound heterozygous for p. L318P and p. R390P and CRISPR generated NGLY1 knockout iPSCs. We demonstrate that NGLY1 deficient midbrain organoids show altered neuronal development compared to one wild type (WT) organoid. Both neuronal (TUJ1) and astrocytic glial fibrillary acid protein markers were reduced in NGLY1 patient-derived midbrain organoids along with neurotransmitter GABA. Interestingly, staining for dopaminergic neuronal marker, tyrosine hydroxylase, revealed a significant reduction in patient iPSC derived organoids. These results provide a relevant NGLY1 disease model to investigate disease mechanisms and evaluate therapeutics for treatments of NGLY1 deficiency.

1 September 2026 in Briefings in Bioinformatics
Verified
Journal Article
Open access
HNHa Nguyen
Ha Nguyen
KNKhoi Nguyen
Khoi Nguyen
PBPhi Bya
Phi Bya
TATarik Alafif
Tarik Alafif
TQTho T Quan
Tho T Quan
TNTin Nguyen
Tin Nguyen
Single-cell RNA sequencing provides high-resolution insights into cellular heterogeneity but its widespread application is often constrained by high costs and technical complexity. Cellular deconvolution serves as a cost-effective alternative by computationally estimating cell-type proportions from bulk RNA-seq data. However, the extreme dynamic range and inherent heteroscedasticity of transcriptomic data pose significant challenges for accurate estimation. Here, we present deconvolution via optimized power-transformed unmixing with shrinkage (DeOPUS), a reference-based deconvolution method that introduces a hierarchical shrinkage transformation (HST) to robustly estimate cellular compositions. DeOPUS integrates multi-level adaptive priors, variance-stabilizing power transformations, and rank-based quantile normalization to mitigate the influence of outliers and high-variance technical noise. We systematically benchmark DeOPUS against eight state-of-the-art methods across 122 tissues and 12 organ systems. DeOPUS consistently outperforms all eight competitors by having mean Pearson ($r = 0.82$) and Spearman ($\rho = 0.77$) correlations. DeOPUS significantly surpasses the second-best method ($r = 0.75, \rho = 0.68$) while maintaining the lowest mean squared error (MSE = 0.007). Notably, DeOPUS ranks first in the vast majority of tissues and organ systems using all three metrics, demonstrating unrivaled robustness to increasing cellular complexity. More in-depth validation on 18 bulk datasets with experimentally determined cell-type proportions further confirms DeOPUS’s strong performance. DeOPUS is the sole method to achieve positive correlations across all datasets, and achieves the highest accuracy for dominant cell-type identification. DeOPUS is available as an open-source R package at https://github.com/tinnlab/DeOPUS.

18 April 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
CCChing-Lan Chang
Ching-Lan Chang
MMMichael A. Moshi
Michael A. Moshi
QNQuang-Huy Nguyen
Quang-Huy Nguyen
JOJunghun Oh
Junghun Oh
HNHa Nguyen
Ha Nguyen
EOEdwin C. Oh
Edwin C. Oh
The rapid evolution of antifungal resistance in Candidozyma auris (formerly Candida auris) presents significant challenges for conventional public health surveillance methods, particularly in detecting emergent and highly transmissible drug-resistant variants. Here, using wastewater-based epidemiology tools initially developed during the COVID-19 pandemic, we implement a high-resolution, facility-level early warning system to monitor C. auris infections and resistance patterns. Our evaluation across Southern Nevada demonstrates that upstream sewage monitoring at healthcare facilities provides significant sensitivity (p < 0.001) compared to wastewater treatment plant sampling. By combining amplicon sequencing and MALDI-TOF mass spectrometry, we identify clinically-relevant, resistance-associated variants in wastewater samples, while whole-genome sequencing reveals >90% genomic concordance between 443 wastewater-derived genomes and 2945 clinical isolates. We also detect previously unreported subclades and resistance mutations, including FKS1 Phe635Leu and co-occurring ERG11/FKS1 variants in wastewater samples up to nearly five months before their appearance in clinical settings. Transcriptomic profiling of drug-resistant isolates under antifungal and stress conditions identifies previously uncharacterized adaptation mechanisms, including differential regulation of ribosomal assembly pathways and cell cycle checkpoints. These findings highlight how wastewater intelligence can enhance traditional public health approaches for early detection and monitoring of C. auris outbreaks and antifungal resistance.

11 November 2025 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
YPYen Thi-Hai Pham
Yen Thi-Hai Pham
BNBac Nhi Nguyen
Bac Nhi Nguyen
TNThinh Gia Nguyen
Thinh Gia Nguyen
AHAnh Huy Hoang
Anh Huy Hoang
TNTan Trong Nguyen
Tan Trong Nguyen
NLNgoan Tran Le
Ngoan Tran Le
Background: Iron is one of the essential elements for human life. Prior studies provided inconclusive results about the association between dietary iron intake and gastric cancer risk. We determined the association between dietary iron intake and the risk of gastric cancer in a case–control study of 1,182 incident gastric cancer cases and 2,965 controls in Vietnam. Methods: We used a validated, semiquantitative food frequency questionnaire to obtain dietary information, including dietary iron intake. An unconditional regression model was used to calculate OR and 95% confidence intervals (95% CI) of gastric cancer in relation to dietary iron intake, adjusted for potential confounders. Results: We observed a U-shaped association between dietary iron intake and gastric cancer risk. Compared with category 2 (reference group), the ORs and 95% CIs of category 1 (lowest intake) and categories 3, 4, 5, and 6 were 1.64 (1.27–2.12), 1.17 (0.90–1.53), 1.35 (1.01–1.82), 1.65 (1.18–2.31), and 2.00 (1.36–2.95; Ptrend < 0.001), respectively. This U-shaped association was also observed in both sexes, in all types of dietary iron intake (i.e., heme and nonheme), and among individuals with noncardia gastric cancer. This pattern was more apparent among individuals with a body mass index < 23 kg/m2 (Pheterogeneity = 0.02), never smokers (Pheterogeneity = 0.02), those without a family history of cancer (Pheterogeneity = 0.99), and individuals with blood group O (Pheterogeneity = 0.98) but showed up in both alcohol and coffee drinkers. Conclusions: We found a U-shaped association between dietary iron intake and gastric cancer risk. Impact: Results from our study also provide evidence for a tailored dietary intervention program that would benefit specific populations and those living in similar settings.